Drug Profile
Factor IX gene therapy - Cell Genesys
Alternative Names: Haemophilia B gene therapy - Cell GenesysLatest Information Update: 24 Oct 2021
Price :
$50
*
At a glance
- Originator Cell Genesys
- Developer Cell Genesys; Nonindustrial source
- Class Blood coagulation factors; Coagulants; Gene therapies
- Mechanism of Action Factor IX stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Haemophilia B